231 completed, 51 unknown, 33 terminated, 14 recruiting. 164 Phase 2, 110 Phase 1, 35 Not applicable, 28 Phase 3, 8 Early Phase 1.
Follow Melanoma (Skin): new trials by email Literature Review of Melanoma (Skin) trials Research Report on Melanoma (Skin)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma Fianlimab, Cemiplimab - Melanoma (Skin) | Phase 2 | Not yet recruiting | University of California, Irvine | 35 | 2026-12-01 | 2026-09-11 |
| A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors ENV-501 - Melanoma (Skin), Non Small Cell Lung Cancer | Phase 1 / Phase 2 | Recruiting | Hummingbird Bioscience | 180 | 2025-12-17 | 2026-03-02 |
| Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma Digizorg Melanoma app - Melanoma (Skin), Melanoma, Stage II, Stage I | Not applicable | Recruiting | Erasmus Medical Center | 180 | 2025-04-01 | 2025-06-11 |
| Real-life Pharmacological Monitoring of Encorafenib-Binimetinib in the Treatment of Metastatic Melanoma Melanoma (Skin) | Recruiting | Assistance Publique - Hôpitaux de Paris | 66 | 2025-01-02 | 2025-03-18 | |
| Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma Pembrolizumab, Cyclophosphamide - Melanoma, Melanoma Stage III | Phase 2 | Recruiting | University of California, Irvine | 14 | 2024-12-23 | 2026-03-10 |
| Head and Neck Melanoma; Access to Staging and Surgical Treatment Melanoma (Skin), Melanoma | Completed | Hull University Teaching Hospitals NHS Trust | 86000 | 2024-10-01 | 2025-04-04 | |
| High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial Exercise Program, Diet Program - Melanoma (Skin), Skin Cancer | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 40 | 2024-07-01 | 2026-08-19 |
| A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma C-PAN, Nivolumab, Ipilimumab - Melanoma (Skin) | Phase 1 | Active not recruiting | University Health Network, Toronto | 12 | 2024-06-24 | 2026-06-08 |
| Rural Adult and Youth Sun Protection Study RAYS Intervention - Melanoma (Skin), Skin Cancer | Not applicable | Recruiting | University of Utah | 843 | 2024-04-08 | 2026-08-10 |
| Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin BCD-263, Opdivo - Advanced Melanoma, Melanoma (Skin) | Phase 3 | Active not recruiting | Biocad | 392 | 2024-03-21 | 2025-07-08 |
| Leaderboard Influence on Self-Regulated Training in a Gamified Dermoscopy Training App Daily updated ranking on leaderboard, Daily motivational message - Melanoma (Skin), Skin Cancer | Not applicable | Unknown | Herlev Hospital | 150 | 2024-01-27 | 2024-02-12 |
| Safety and Avoidance of Futile Excisions Through Skin Tele-triage Single Assessor Teledermatological triage (TDT), 2 people Teledermatological triage (TDT), 3 people Teledermatological triage (TDT) - Melanoma (Skin), Telemedicine | Completed | Herlev Hospital | 5 | 2023-09-01 | 2024-10-08 | |
| Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number. Sodium Chloride Granules, Water - Melanoma (Skin) | Phase 2 | Unknown | Rafik Batroussy | 20 | 2023-08-01 | 2023-05-11 |
| Dermoscopy Augmented Histology Trial, Consensus Agreement Diagnosis Made by Dermatopathology Experts Melanoma (Skin), Pigmented Lesions | Completed | Herlev Hospital | 4 | 2023-04-24 | 2026-06-25 | |
| A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma BCD-217, anti-PD1, Excision of the primary lesion - Melanoma Stage III, Melanoma (Skin) | Phase 3 | Active not recruiting | Biocad | 411 | 2023-04-05 | 2025-07-08 |
| LifeChamps Feasibility Study LifeChamps Platform - Melanoma (Skin) | Not applicable | Unknown | Region Stockholm | 20 | 2023-03-01 | 2023-08-14 |
| Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab - Melanoma (Skin) | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 30 | 2023-02-23 | 2026-07-16 |
| Mentored Community Gardening for Individuals With Skin Cancer Mentored Community Gardening - Melanoma, Cancer Survivorship | Not applicable | Completed | University of Arizona | 29 | 2023-02-02 | 2025-05-04 |
| START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer PeptiCRAd-1, Cyclophosphamide, Pembrolizumab - Melanoma (Skin), Triple-Negative Breast Cancer | Phase 1 | Recruiting | Valo Therapeutics Oy | 15 | 2023-02-02 | 2026-05-12 |
| Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors Evaluation of cytokine production - Melanoma (Skin) | Not applicable | Recruiting | Centre Hospitalier Universitaire de Nice | 60 | 2023-01-31 | 2024-06-04 |
Showing 20 of 351. Sign in to see all of them.
Melanoma (351) · Uveal Melanoma (28) · Carcinoma, Renal Cell (23) · Kidney Neoplasms (23) · Neoplasm Metastasis (21) · Breast Neoplasms (19) · Skin Neoplasms (19) · Carcinoma, Non-Small-Cell Lung (13) · Lung Neoplasms (13) · Brain Neoplasms (12) · Ovarian Neoplasms (12) · Sarcoma (12) · Carcinoma, Basal Cell (11) · Colorectal Neoplasms (10) · Neoplasms (9)
Neoplasms by Histologic Type (351) · Neoplasms by Site (351) · Neoplasms, Nerve Tissue (351) · Neuroectodermal Tumors (351) · Neuroendocrine Tumors (351) · Nevi and Melanomas (351) · Skin and Connective Tissue Diseases (351) · Neoplasms, Germ Cell and Embryonal (350) · Skin Diseases (350) · Neoplasms (342) · Skin Neoplasms (332) · Neoplasms, Glandular and Epithelial (50) · Carcinoma (43) · Urogenital Diseases (34) · Female Urogenital Diseases (33)
aldesleukin (50) · incomplete Freund's adjuvant (34) · sargramostim (26) · Cyclophosphamide (20) · Interferon-alpha (20) · MART-1 Antigen (18) · fludarabine phosphate (16) · Temozolomide (15) · Filgrastim (14) · Gene Expression Profiling (12) · Nivolumab (12) · Chemotherapy, Adjuvant (9) · Immunohistochemistry (9) · Ipilimumab (9) · Dacarbazine (8)
National Cancer Institute (NCI) (28) · Memorial Sloan Kettering Cancer Center (15) · National Institutes of Health Clinical Center (CC) (12) · Eastern Cooperative Oncology Group (11) · Alliance for Clinical Trials in Oncology (10) · European Organisation for Research and Treatment of Cancer - EORTC (10) · H. Lee Moffitt Cancer Center and Research Institute (10) · SWOG Cancer Research Network (8) · Fred Hutchinson Cancer Center (7) · Mayo Clinic (7) · University of Southern California (7) · Jonsson Comprehensive Cancer Center (6) · ECOG-ACRIN Cancer Research Group (5) · University of Chicago (5) · University of Virginia (5)
United States (241) · United Kingdom (28) · France (21) · Germany (19) · Canada (14) · Italy (14) · Australia (12) · Netherlands (12) · Belgium (11) · Russia (11) · Switzerland (10) · Spain (9) · Portugal (8) · Austria (7) · Denmark (6)
Steven A. Rosenberg, MD, PhD (27) · Craig L. Slingluff, MD (9) · Jeffrey S. Weber, MD, PhD (9) · Svetomir Markovic, MD, PhD (9) · Cassian Yee, MD (5) · John M. Kirkwood, MD (5) · Antoni Ribas, MD (4) · Gerold Schuler (4) · Julia Newton Bishop, MD (4) · Paul B. Chapman, MD (4) · Robert O. Dillman, MD, FACP (4) · Thomas F. Gajewski, MD, PhD (4) · Alexander M. M. Eggermont, MD, PhD (3) · David M. Gustin, MD (3) · Jedd D. Wolchok, MD (3)
PMID 25667295, PMID 20856802, PMID 10733633, PMID 10811235, PMID 10890744, PMID 11410496, PMID 11595689, PMID 12039921, PMID 12684398, PMID 12826605, PMID 12833467, PMID 12947072, PMID 14581425, PMID 14665609, PMID 15073859, PMID 15122079, PMID 15534491, PMID 15598954, PMID 15937544, PMID 16007689, PMID 16034524, PMID 16087944, PMID 16170182, PMID 16198768, PMID 16237114, PMID 16260693, PMID 16283570, PMID 16314647, PMID 16551859, PMID 16699374, PMID 16706633, PMID 17023156, PMID 17438101, PMID 17443000, PMID 17551310, PMID 17932881, PMID 17962907, PMID 18048828, PMID 18406492, PMID 18483359, PMID 18620949, PMID 18809608, PMID 19001327, PMID 19060590, PMID 19196482, PMID 19228745, PMID 19270751, PMID 19282789, PMID 19404399, PMID 19433686
P30CA015083 (7), U10CA032102 (6), P30CA072720 (4), 2019 (3), P30CA008748 (3), P30CA022453 (2), P30CA023108 (2), U10CA021115 (2), 2004 (1), 2017 (1), 2018 (1), P30CA006973 (1), P30CA011198 (1), P30CA014089 (1), P30CA014520 (1)